FactorPad
FinTech Dev and Data

Stock Risk Measures for Syneos Health Inc

A quantitative factor review, as of July 31, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: August 02, 2020
See how we arrive at an overall risk score of 57 for SYNH below.

/ factorpad.com / stocks / f47kzd.html



SYNH Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Syneos Health Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SYNH stock compares to 2,000+ US-based stocks, and to peers in the Health Services sector and Services to the Health Industry industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f47kzd.html


SYNH stock risk
SYNEOS HEALTH INC stock beta
SYNH risk report
SYNH f47kzd
SYNH risk analysis
SYNH volatility
SYNEOS HEALTH INC credit risk
SYNH liquidity risk
SYNH leverage
SYNH valuation
SYNH systematic risk
SYNH specific risk
SYNEOS HEALTH INC volatility
SYNH analysis
SYNH financial ratio